Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,655.00
+35.00 (1.34%)
At close: Jul 21, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 51.07 billion as of July 21, 2026. Its market cap has decreased by -33.71% in one year.
Market Cap
51.07B
Enterprise Value
50.02B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,655.00
ChartMarket Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 51.07B, a decrease of -79.94%. That is a compound annual growth rate of -23.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 51.07B | -31.57% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 63.40B |
| PanGen Biotech | 61.69B |
| ABION | 60.82B |
| Aptamer Sciences | 57.44B |
| Naturalendo Tech | 56.64B |
| ADBiotech | 52.80B |
| TegoScience | 51.64B |
| IMGT Co.,Ltd. | 51.51B |